2.13
Il diabete mellito di tipo 1 nasce da una distruzione immunitaria delle cellule β pancreatiche, che porta a una carenza assoluta di insulina. Questo p…
Nel diabete di tipo 1, fattori genetici e ambientali contribuiscono a una risposta autoimmune in cui il sistema immunitario attacca le cellule beta produttrici di insulina nel pancreas.
Queste cellule beta risiedono in gruppi chiamati isolotti di Langerhans e sono responsabili della produzione di insulina, un ormone che permette al glucosio di entrare nelle cellule per energia o accumulo.
Con lo svolgimento del processo autoimmune, le cellule T helper 1 si attivano e rilasciano citochine infiammatorie, come interferone-gamma o IFN-γ, e fattore di necrosi tumorale-alfa o TNF-α.
In particolare, l'IFN-γ attiva i macrofagi e rafforza la presentazione dell'antigene. Questi segnali permettono alle cellule T citotossiche di attaccare e distruggere le cellule beta, portando all'insulite, caratterizzata da infiammazione e danni alle cellule beta negli isolotti di Langerhans.
Col tempo, l'infiammazione persistente distrugge progressivamente le cellule beta, riducendo drasticamente o eliminando completamente la produzione di insulina.
Senza abbastanza insulina, il glucosio non può entrare nelle cellule del corpo e inizia ad accumularsi nel flusso sanguigno.
Questo accumulo di zucchero nel sangue porta a una condizione nota come iperglicemia.
View the full transcript and gain access to JoVE Core videos
Q1: What role do the islets of Langerhans play in type 1 diabetes?
The islets of Langerhans are clusters of cells in the pancreas containing beta cells that produce insulin. In type 1 diabetes, these islets become inflamed through an autoimmune process called insulitis, where immune cells attack and destroy the insulin-producing beta cells, progressively reducing insulin production.
Q2: How do T helper 1 cells contribute to beta cell destruction in type 1 diabetes?
T helper 1 cells become activated against beta cell antigens and release pro-inflammatory cytokines, including interferon-gamma and tumor necrosis factor-alpha. These cytokines activate macrophages, enhance antigen presentation, and enable cytotoxic T cells to attack and destroy beta cells, perpetuating the autoimmune response.
Q3: What is the relationship between insulin deficiency and hyperglycemia in type 1 diabetes?
Insulin is required for glucose uptake into cells for energy or storage. Without sufficient insulin from destroyed beta cells, glucose cannot enter muscle and adipose tissue and accumulates in the bloodstream, causing hyperglycemia. This blood sugar buildup marks the clinical onset of type 1 diabetes.
Q4: How do genetic and environmental factors initiate the autoimmune response in type 1 diabetes?
Type 1 diabetes develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge. Genetic predisposition, including susceptibility alleles within HLA loci, influences autoimmune likelihood, while environmental triggers such as viral infections may precipitate or accelerate beta cell injury.
Q5: What is insulitis and how does it damage pancreatic beta cells?
Insulitis is an inflammatory infiltration of the islets of Langerhans characterized by T cells, macrophages, and other immune effectors. Chronic exposure to cytotoxic mediators from these immune cells leads to apoptosis and progressive depletion of beta cell mass, eventually eliminating insulin production capacity.
Q6: How does interferon-gamma amplify the immune attack on beta cells?
Interferon-gamma, released by activated T helper 1 cells, plays a central role in amplifying the immune response by promoting macrophage activation and enhancing antigen presentation. These enhanced signals allow cytotoxic T cells to more effectively recognize and attack beta cells, intensifying the autoimmune destruction.
Q7: What distinguishes type 1 diabetes from other forms of diabetes mellitus?
Type 1 diabetes results from immune-mediated destruction of pancreatic beta cells, causing absolute insulin deficiency. This contrasts with other diabetes types where insulin production may be preserved but ineffective. Understanding type 1 diabetes pathophysiology helps explain its acute onset and distinct clinical presentation compared to other forms.